$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Can fenelidone be taken long-term? Treatment cycle and patient medication recommendations
2026-02-01 22:25:32
Check Details
What is the difference between domestically produced and imported rasagiline? Effect of drug source on treatment
2026-02-01 22:25:32
Check Details
Larotrectinib welcomes breakthrough in treating NTRK fusion tumors: new data on indication expansion and long-term efficacy released
2026-02-01 22:25:32
Check Details
New data released on Tarlatamab: new hope for improving survival in small cell lung cancer
2026-02-01 22:25:32
Check Details
Pemetinib/pemetinib domestic price 2025 latest price per bottle
2026-02-01 22:25:32
Check Details
What are the main functions and therapeutic effects of erdafitinib?
2026-02-01 22:25:32
Check Details
Detailed explanation of dacomitinib/dacomitinib usage and instructions guide
2026-02-01 22:25:32
Check Details
The latest price and purchasing information of brigatinib/brigatinib
2026-02-01 22:25:32
Check Details
Entrectinib reaches objective response rate endpoint in ROS1+ non-small cell lung cancer
2026-02-01 22:25:32
Check Details
Acotinib plus bendamustine and rituximab shows long-term activity in first-line and MCL R/R
2026-02-01 22:25:32
Check Details
Reducing ibrutinib dose to maintain BTK inhibition in CLL data model
2026-02-01 22:25:32
Check Details
What important information is included in the instructions for ruxolitinib tablets/ruxolitinib
2026-02-01 22:25:32
Check Details
1
2
...
1515
1516
1517
1518
1519
1520
1521
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer
2
Venetoclax Therapy Guidelines: Balancing Precision Targeting with Risk Management
3
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
4
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
5
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
6
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
7
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
8
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
9
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
10
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
11
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
12
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration